LI
BLUE

LMCG Investments’s bluebird bio BLUE Stock Holding History

LMCG Investments’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2,151
Closed -$585K – 472
2013
Q4 		$585K Buy
+2,151
New +$601K 0.01% 414

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

LMCG Investments's BLUE Position: Q1 2014 in Review

LMCG Investments sold out of bluebird bio (BLUE) in Q1 2014, closing a stake of 2,151 shares — an estimated $585K sold.

LMCG Investments first reported a position in BLUE in Q4 2013 and held it in 1 quarter. The position peaked at $585K in Q4 2013. 83 funds tracked by Wall St. Rank hold BLUE as of Q1 2014.

  • LMCG Investments reported no remaining bluebird bio position as of Q1 2014 after selling out during the quarter.
  • LMCG Investments sold 2,151 bluebird bio shares in Q1 2014, an estimated $585K.
  • LMCG Investments first reported a position in bluebird bio in Q4 2013 and held it in 1 quarter.
  • LMCG Investments's bluebird bio position peaked at $585K in Q4 2013.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q1 2014.

Based on LMCG Investments's 13F filing for Q1 2014, filed 12 May 2014.